KGI Partners with City of Hope for Biomedical Innovation and Commercialization Program
On February 2, 2021, Keck Graduate Institute reported, City of Hope, a world-class biomedical research institution and comprehensive cancer center, has collaborated with Keck Graduate Institute (KGI) for programs such as the Master of Science in Translational Medicine and the Certificate in Bioscience Management. Recently, City of Hope and KGI have developed a Biomedical Innovation and Commercialization (BIC) program for City of Hope faculty that demonstrates how biomedical innovation and commercialization efforts drive patient benefit and fuel ongoing scientific discovery.
The inaugural BIC course is the first of its kind at City of Hope and the surrounding LA area. In collaboration with KGI, the workshop is tailored to City of Hope faculty members interested in commercialization. It will offer a unique opportunity to access an unparalleled set of experts from within City of Hope and other biomedical institutions.
City of Hope blends the best of academics, medical care, and biotech—a concept they call the “R&D hybrid.” This approach to R&D can mean that an innovative discovery might be spun out into a startup company or licensed to an existing biopharmaceutical company. The ultimate goal is speeding discoveries to patients by fast-tracking the commercialization of potentially life-changing new therapies.
The unique program is led by Dr. Ildiko Csiki, Chief Commercial R&D Officer at City of Hope, and Dr. Harlan Levine, President of Strategy and Business Ventures at City of Hope.
To read the full article click HERE
